Combination Therapy of Niacin and Apocynin Attenuates Lung Injury During Sepsis in Rats

J Surg Res. 2023 May:285:51-58. doi: 10.1016/j.jss.2022.12.020. Epub 2023 Jan 12.

Abstract

Introduction: Oxidative stress contributes to tissue injury through reactive oxygen species-dependent signaling pathways during sepsis. We studied therapeutic benefits of the combination therapy of niacin, which increased reduced glutathione levels, and apocynin, which suppressed reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) activity, in septic rats.

Materials and methods: Polymicrobial sepsis was induced through cecal ligation and puncture (CLP) with antibiotics in male Sprague-Dawley rats (n = 189). The rats were randomly divided into sham, CLP, CLP + niacin, CLP + apocynin, and CLP + niacin + apocynin groups. Six hours after CLP, vehicle, niacin (360 mg/kg through the orogastric tube), and/or apocynin (20 mg/kg through intraperitoneal injection) were administered. The occurrence of mortality for 72 h after CLP was observed. Next, a separate set of animals was euthanized at 24 h post-CLP for lung tissue analyses.

Results: Combination therapy with niacin and apocynin significantly improved survival in rats with sepsis (75.0% versus 28.8%, P = 0.006) but monotherapy with niacin or apocynin did not. Monotherapy with niacin and apocynin appeared to increase NADPH levels and decrease Nox levels and activity, respectively, but failed to show statistical significances. However, combination therapy significantly decreased Nox levels and activity, increased NADPH and glutathione levels, decreased intranuclear nuclear factor-κB (NF-κB) p65 levels, reduced inflammatory cytokine expression and malondialdehyde levels, and attenuated histological lung injuries.

Conclusions: Combination therapy with niacin and apocynin synergistically attenuated lung injuries and improved survival in rats with sepsis through niacin-induced glutathione redox cycle activation and apocynin-induced Nox suppression.

Keywords: Apocynin; Glutathione; Niacin; Nuclear factor κB; Reactive oxygen species; Sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetophenones* / pharmacology
  • Animals
  • Glutathione / therapeutic use
  • Lung / pathology
  • Lung Injury* / drug therapy
  • Male
  • NADP / metabolism
  • NADPH Oxidases / metabolism
  • NF-kappa B / metabolism
  • Niacin* / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Sepsis* / metabolism

Substances

  • acetovanillone
  • Glutathione
  • NADP
  • NADPH Oxidases
  • NF-kappa B
  • Niacin
  • Acetophenones